RHOEN-KLINIKUM O.N./ DE0007042301 /
3/29/2023 5:36:03 PM | Chg. -0.050 | Volume | Bid3/29/2023 | Ask3/29/2023 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
12.500EUR | -0.40% | 2,774 Turnover: 35,768.500 |
-Bid Size: - | -Ask Size: - | 837.03 mill.EUR | 0.00% | 29.76 |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 0.42 EUR | 2,000.00% |
EPS Diluted: | 0.42 EUR | 2,000.00% |
Revenues per Share: | 20.94 EUR | 3.07% |
Book Value per Share: | 17.90 EUR | 2.83% |
Cash Flow per Share: | 1.46 EUR | -13.95% |
Dividend per Share: | 0.00 EUR | - |
Total | in mill. | |
Revenues: | 1,402.00 EUR | 3.07% |
Net Income: | 28.30 EUR | 1,786.67% |
Operating Cash Flow: | 97.50 EUR | - |
Cash and Cash Equivalents: | 126.30 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 29.76 | 34.24 |
P/S Ratio: | 0.60 | 0.69 |
P/BV ratio: | 0.70 | 0.80 |
P/CF Ratio: | 8.58 | 9.88 |
PEG: | 0.01 | 0.02 |
Earnings Yield: | 3.36% | 2.92% |
Dividend Yield: | 0.00% | 0.00% |
Market Capitalization | ||
Market Capitalization: | 837.03 mill. EUR | 962.91 mill. EUR |
Free Float Market Cap.: | 55.41 mill. EUR | 63.74 mill. EUR |
Market Cap. / Employee: | 45,922.2582 EUR | 52,828.9658 EUR |
Shares Outstanding: | 66.96 mill. |
Profitability
Gross Profit Margin: | 3.58% |
EBIT Margin: | 2.18% |
Net Profit Margin: | 2.02% |
Return on Equity: | 2.36% |
Return on Assets: | 1.70% |
Financial Strength
Liquidity I / Cash Ratio: | 46.21% |
Liquidity II / Quick Ratio: | 124.11% |
Liquidity III / Current Ratio: | 223.60% |
Debt / Equity Ratio: | 39.00% |
Dynam. Debt / Equity Ratio: | 479.28% |
Efficiency
Employees: | 18,227 |
Personal Expenses / Employee: | 50,551.38 EUR |
Revenues / Employee: | 76,918.86 EUR |
Net Income / Employee: | 1,552.64 EUR |
Total Assets / Employee: | 91,380.92 EUR |
* Fiscal Year End: | 12/31/2021 |
Accounting Standard: | IFRS |
Currency: | EUR |